Cell & Gene Therapy Contract Research Organizations Market

The Cell & Gene Therapy Contract Research Organizations (CRO) market provides specialized, end-to-end development services for advanced therapies. Key customers are biopharmaceutical companies, academic institutions, and research organizations that need support with complex clinical, regulatory, and manufacturing processes. The market's growth is driven by the rapid expansion of cell and gene therapy pipelines, increasing investment from biotech and pharma, and favorable regulatory pathways accelerating product approvals.